Literature DB >> 3141162

Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis.

M L Fernández-Guerrero1, C Barros, J L Rodriguez Tudela, R Fernández Roblas, F Soriano.   

Abstract

A case is reported of a patient who developed aortic endocarditis after protracted hospitalization during which time the patient received multiple courses of aminoglycoside and cephalosporin therapy. The infecting organism, an Enterococcus faecalis strain, was resistant to gentamicin and to the combination of ampicillin with gentamicin. Valve replacement was performed after four weeks of therapy with ampicillin, and enterococci were isolated from cardiac vegetations. Valve replacement may be necessary to achieve cure of endocarditis due to enterococci highly resistant to gentamicin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141162     DOI: 10.1007/bf01962605

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis.

Authors:  R C Moellering; B E Murray; S C Schoenbaum; J Adler; C B Wennersten
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

2.  Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.

Authors:  J Y Matsumoto; W R Wilson; A J Wright; J E Geraci; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

3.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

4.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08

5.  Ampicillin in the treatment of enterococcal endocarditis.

Authors:  H N Beaty; M Turck; R G Petersdorf
Journal:  Ann Intern Med       Date:  1966-10       Impact factor: 25.391

6.  Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

Authors:  C Thauvin; G M Eliopoulos; S Willey; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  Significance of in-vitro penicillin tolerance in experimental enterococcal endocarditis.

Authors:  K S Kim; A S Bayer
Journal:  J Antimicrob Chemother       Date:  1987-04       Impact factor: 5.790

8.  Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

Authors:  W R Wilson; C J Wilkowske; A J Wright; M A Sande; J E Geraci
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

9.  Optimal therapy for enterococcal endocarditis.

Authors:  J Herzstein; J L Ryan; R J Mangi; T P Greco; V T Andriole
Journal:  Am J Med       Date:  1984-02       Impact factor: 4.965

10.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  10 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

Review 3.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 4.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

5.  Risk factors for acquisition of gentamicin-resistant enterococcal infection: a case-controlled study.

Authors:  M Viagappan; R E Holliman
Journal:  Postgrad Med J       Date:  1999-06       Impact factor: 2.401

Review 6.  Therapy of enterococcal infections.

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 7.  Clinical manifestations of enterococcal infection.

Authors:  C M Lewis; M J Zervos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

8.  Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.

Authors:  J Gavaldà; C Torres; C Tenorio; P López; M Zaragoza; J A Capdevila; B Almirante; F Ruiz; N Borrell; X Gomis; C Pigrau; F Baquero; A Pahissa
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

9.  Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms.

Authors:  Martin E. Stryjewski; Vivian H. Chu; Christopher H. Cabell; Vance G. Fowler
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

10.  Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.

Authors:  W C Hellinger; M S Rouse; P M Rabadan; N K Henry; J M Steckelberg; W R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.